Cyclophosphamide is probably one of the most prescribed anticancer drugs used for 22 treatment of various forms of cancers. It is nitrogen mustard whose mode of action 23 involves addition of alkyl groups to DNA thus slowing or stopping tumour growth 24 (Bauman et al., 2001) . Besides the cytotoxic effects of cyclophosphamide towards 25 tumour cells, it also affects other cell types in the body most notably the immune cells 26 which protect the body from harmful agents (Hou et al., 2007) . Immunosuppression 27 caused by cyclophosphamide and other anticancer drugs significantly complicates the 28 course of cancer chemotherapy and worsens the condition of the patients. 29
30
In regard to the immunosuppressive effects of anticancer chemotherapy, the stimulation 31 of production of immune cells in an immunosuppression model has been classified as 32 immunomodulation (Vigila et al., 2008) . In fact, attempts are being made to incorporate 33 traditional medicines with cancer chemotherapy to reduce the side effects of anticancer 34 drugs through this immunomodulation (Gupta et al., 2010; Shukla, et al., 2010) . There is 35 growing interest among biomedical scientists in the ability of some natural products to 36 stimulate the production of immune cells in immunosuppressed animal models. Several 37 sources including mushrooms are being screened for immunomodulatory compounds 38 that can be used to enhance cancer chemotherapy. two genera which are yet to be identified and their medicinal potential profiled. Moreover, 48 in many tropical countries, mushrooms comprise a vast and yet largely untapped source 49 of powerful new pharmaceutical products and they represent an unlimited source of 50 polysaccharides with antitumour and immunostimulating properties (Wasser, 2002) . In 51 Uganda, Auricularia sp (wood ear) and Pleurotus sp (oyster) mushrooms which naturally 52 grow on decaying logs in the rainforests are believed to be traditionally used for 53 medicinal purposes by local communities for treatment of various ailments. 54
Polysaccharides, proteins and other compounds previously isolated from mushroom 55 species of these two genera have been found to stimulate immune cells both in vitro and 56 in vivo (Synistya, et al., 2008) . Indeed, there is a great deal of evidence that species from 57 these two genera might be a potential source of immunomodulatory compounds that can 58 benefit patient care. In this study, we investigated the potential benefits of the aqueous 59 extracts of a Pleurotus sp. and Auricularia sp. wild mushrooms on markers of 60 cyclophosphamide induced immunosuppression in using male Wistar rat model. 
Experimental design 83
The immunosuppression model for cyclophosphamide developed by Hou et al., (2007) , 84
in Wistar albino rats was used to evaluate the immunomodulatory effect of the 85 mushroom extracts. Eighty (80) healthy male Wistar albino rats were randomized into 86 eight groups (n=10). Wistar rats from 5 groups had induction of immunosuppression 87 using 10mg/kg body weight cyclophosphamide and then received either mushroom 88 extracts or distilled water as follows; 89 
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The experimental animals were handled in accordance with the
RESULTS AND DISCUSSION
123
Wistar rats treated with cyclophosphamide alone (Group I) had significant reduction in 124 total white blood cells (WBC) (p < 0.001; Table 1 ) and differential white blood cell (i.e. 125
Lymphocyte and Neutrophils) counts on days 14 and 28 compared to day 0 (Table 2 &  126 3). In addition to cyclophosphamide, Auricularia sp (Group II & III) and Pleurotus sp 127 (Group IV&V) extract treated rats had moderate reductions in total WBC and differential 128 white cell counts on days 14 and 28 compared to day 0. The mean WBC counts in 129 extract treated rats were all greater than those of Group I at day 14 & 28 (Table 1) . The 130 rise in the total WBC count lowered by cyclophosphamide in Wistar rats was observed at 131 300 mg/kg and 600mg of Auricularia sp, and 400mg/kg and 800mg/kg for Pleurotus sp 132 extract. Hence, both extracts had a dose dependent increase in stimulation of WBC 133 although Auricularia sp extract had higher total WBC compared to Pleurotus treated rats. 134
The Wistar rats treated with both mushroom species aqueous extracts had their white 135 cell counts restored to almost near initial levels recorded on day 0 which were 136 significantly greater than those observed in the control group. There was a significant 137 increment in total and differential white cell counts in normal Wistar rats treated with 138 300mg/kg Auricularia extract (i.e. Group VI; p< 0.001) and 400mg/kg Pleurotus sp 139 extract (i.e. Group VII; p < 0.05) compared to those in the control group (Tables 1, 2 In our study, administration of cyclophosphamide at 10mg/kg to daily to Wistar rats 153 successfully caused significant immunosuppression as previously described in a similar 154 animal model (Hou et al., 2007) . Both total and differential WBC counts were severely 155 reduced in Wistar rats receiving cyclophosphamide only on days 14 and 28 owing to the 156 effects of the drug on the bone marrow. The bone marrow has a high rate of cell 157 proliferation and this makes it a sensitive target for cyclophosphamide cytotoxicity (Shukla et al., 2010) et al., 2006) . 161
162
The increased WBC number as demonstrated in this study would be an important 163 contributing factor to reduce the risk of various infectious diseases in immunosuppresed 164 patients consuming these two studied mushroom species (Morris et al., 2003) . 
